Youings S A, Murray A, Dennis N, Ennis S, Lewis C, McKechnie N, Pound M, Sharrock A, Jacobs P
Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, Wiltshire SP2 8BJ, UK.
J Med Genet. 2000 Jun;37(6):415-21. doi: 10.1136/jmg.37.6.415.
We report the results of a five year survey of FRAXA and FRAXE mutations among boys aged 5 to 18 with special educational needs (SEN) related to learning disability. We tested their mothers using the X chromosome not transmitted to the son as a control chromosome, and the X chromosome inherited by the son to provide information on stability of transmission. We tested 3738 boys and 2968 mothers and found 20 FRAXA and one FRAXE full mutations among the boys and none among the mothers. This gives an estimated prevalence of full mutations in males of 1 in 5530 for FRAXA and 1 in 23 423 for FRAXE. We found an excess of intermediate and premutation alleles for both FRAXA and FRAXE. For FRAXA this was significant at the 0.001 level but the excess for FRAXE was significant only at the 0.03 level. We conclude that the excess of intermediate and premutation sized alleles for FRAXA may well be a contributing factor to the boys' mental impairment, while that for FRAXE may be a chance finding. We studied approximately 3000 transmissions from mother to son and found five instabilities of FRAXA in the common or intermediate range and three instabilities of FRAXE in the intermediate range. Thus instabilities in trinucleotide repeat size for FRAXA and FRAXE are rare, especially among alleles in the common size range.
我们报告了一项针对5至18岁有学习障碍相关特殊教育需求(SEN)男孩的FRAXA和FRAXE突变的五年调查结果。我们使用未传递给儿子的X染色体作为对照染色体对他们的母亲进行检测,并使用儿子继承的X染色体来提供关于传递稳定性的信息。我们检测了3738名男孩和2968名母亲,在男孩中发现了20个FRAXA完全突变和1个FRAXE完全突变,而在母亲中未发现。这得出FRAXA男性完全突变的估计患病率为1/5530,FRAXE为1/23423。我们发现FRAXA和FRAXE的中间和前突变等位基因均有过量。对于FRAXA,这在0.001水平上具有显著性,但FRAXE的过量仅在0.03水平上具有显著性。我们得出结论,FRAXA中间和前突变大小等位基因的过量很可能是导致男孩智力障碍的一个因素,而FRAXE的过量可能是一个偶然发现。我们研究了大约3000次从母亲到儿子的传递,发现FRAXA在常见或中间范围内有5次不稳定,FRAXE在中间范围内有3次不稳定。因此,FRAXA和FRAXE三核苷酸重复序列大小的不稳定很少见,尤其是在常见大小范围内的等位基因中。